Status:
ACTIVE_NOT_RECRUITING
Implementation Strategies for Monitoring Adherence in Real Time
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Collaborating Sponsors:
Lung Cancer Research Foundation
Pfizer
Conditions:
Lung Cancer
Medication Adherence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this project is to identify effective strategies to help patients with lung cancer manage side effects and achieve optimal adherence to oral targeted therapies. To achieve this object...
Detailed Description
Drawing from insights in behavioral economics and implementation science, the goal of our project is to identify effective strategies for improving lung cancer outcomes by helping patients to better m...
Eligibility Criteria
Inclusion
- Adult patient (age \> 18 years) with NSCLC at UPHS who is receiving one of the following nine oral therapies: afatinib, erlotinib, dacomitinib, gefitinib, osimertinib, alectinib, brigatinib, crizotinib, or lorlatinib.
- Patient possession of a mobile device that can send/receive SMS texts
- Ability to respond to questions and engage with "Penny" in English
- Ability to provide informed consent to participate in the study
- Approval from the patient's medical oncologist to be approached
Exclusion
- Inability to respond to questions and engage with "Penny" in English
- Inability or unwillingness to provide informed consent to participate in the study
- Inability to engage with SMS text-messaging platform
- Concurrent enrollment in a therapeutic clinical trial
- Taking more than one oral targeted therapy or concurrent chemotherapy during the study window
- Lack of approval from the patient's oncologist
Key Trial Info
Start Date :
February 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2025
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04347161
Start Date
February 22 2021
End Date
October 20 2025
Last Update
January 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104